Search For "cova"
ICMR says clinical trial shows COVAXIN is 'safe'
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): Hours after Drugs Controller General of India (DCGI) approved restricted use in an emergency situation to Bharat Biotech's COVID-19 vaccine, Indian Council of Medical Research (ICMR) on Sunday said data generated through pre-clinical studies and various ph
Read More
Kejriwal congratulates nation after emergency approval of 2 COVID-19 vacci
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): Delhi Chief Minister Arvind Kejriwal congratulated people as the Drugs Controller General of India (DCGI) given approval for the emergency use of two vaccines on Sunday.
Read More
Approval to Covaxin premature, could be dangerous: Tharoor
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): Senior Congress leader Shashi Tharoor on Sunday said that the emergency approval to COVID-19 vaccine--Covaxin is premature and could be dangerous as it is still under phase 3 trial. He urged Union Health Minister Dr Harsh Vardhan to wait till full trials o
Read More
30 crore people to be vaccinated against COVID-19 in first phase: Max hosp
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): As the country is eagerly waiting for the COVID-19 vaccination programme to begin, Dr Manoj Kumar, senior cardiologist at Max Hospital, New Delhi said that in the first phase, almost 30 crore population will be covered.
Read More
Recommendation for DCGI nod for restricted emergency use of two COVID-19 v
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): With an expert panel of Drugs Controller General of India (DCGI) recommending grant of restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine on Saturday, doctors said it was a good development as the vaccine i
Read More
COVID-19: Bharat Biotech recruits 23,000 volunteers for COVAXIN's phase 3
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 2 (ANI): Bharat Biotech has recruited 23,000 volunteers so far for the Phase III clinical trials of its COVID-19 vaccine candidate, 'COVAXIN'.
Read More
Expert panel recommends restricted emergency use nod to Bharat Biotech's C
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): An expert panel of Drugs Controller General of India (DCGI) has recommended granting restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine, also known as Covaxin, government sources told ANI on Saturday.
Read More
Government could evaluate AstraZeneca, Covaxin: Dr Vijay Bhaskar
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], December 31 (ANI): The government could evaluate two vaccines including the indigenously researched Covaxin and AstraZeneca to address the Covid-19 pandemic, Dr Vijay Bhaskar, Chairman of the Ethics Committee, Clinical trials and research said on Thursday.
Read More
Vice President discusses status of indigenous vaccine against COVID-19
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], December 25 (ANI): Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella called on the Vice President M Venkaiah Naidu in Hyderabad on Friday.
Read More
Bharat Biotech bosses discuss Covaxin status with Vice-President
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], December 25 (ANI): Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella called on Vice-President M Venkaiah Naidu at his residence on Friday in Hyderabad.
Read More
Indian vaccine Covaxin has drawn global attention: ICMR
Updated : 5 years, 2 months ago IST
New Delhi [India], December 25 (ANI): The Indian Council of Medical Research (ICMR) has said that the Indian vaccine against COVID-19, Covaxin, has drawn global attention.
Read More
AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin
Updated : 5 years, 2 months ago IST
New Delhi [India], December 24 (ANI): The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed COVID-19 vaccine candidate 'Covaxin' for which it is one of the sites.
Read More